Moneycontrol
Get App
SENSEX NIFTY
you are here:

Brooks Laboratories Ltd.

BSE: 533543 | NSE: BROOKS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE650L01011 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 22, 16:00
37.20 -0.70 (-1.85%)
Volume
AVERAGE VOLUME
5-Day
3,802
10-Day
3,996
30-Day
7,493
2,457
  • Prev. Close

    37.90

  • Open Price

    38.05

35.10

Today’s L/H

39.90
22.05

52 Wk L/H

63.40
30.35

L/U Price Band

45.45
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    38.65
     Beta
    1.30
  • Market Depth (22 Jan 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    1 37.70 38.50 100
    109 37.20 39.00 1500
    500 37.05 39.90 18
    1 37.00 39.95 50
    1000 35.25 40.00 2
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Jan 22, 15:44
38.00 0.00 (0.00%)
Volume
AVERAGE VOLUME
5-Day
26,543
10-Day
34,432
30-Day
45,590
38,491
  • Prev. Close

    38.00

  • Open Price

    38.10

37.60

Today’s L/H

39.75
22.30

52 Wk L/H

63.00
30.40

L/U Price Band

45.60
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    38.00 (1)

  •  VWAP

    38.38
     Beta
    1.33
  • DELIVERY AVERAGES
    3-Day
    62.58%
    5-Day
    63.26%
    8-Day
    57.80%
    Deliverables
  • SMA
    30
    31.71
    50
    30.92
    150
    35.01
    200
    39.41
    SMA
    31.71

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bullish
Moving Averages Bullish
Technical Indicators Bullish
Moving Averages Crossovers Bullish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 39.30 40.60 41.45 38.45 37.15 36.30 35.00
Fibonacci 39.27 39.78 40.60 38.45 37.63 37.12 36.30
Camarilla 38.20 38.39 38.59 38.45 37.80 37.61 37.41

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 38.23
10 36.80
20 33.83
50 30.92
100 32.60
200 39.41
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 41.43 43.82 47.28 37.97 35.58 32.12 29.73
Fibonacci 40.20 41.58 43.82 37.97 35.73 34.35 32.12
Camarilla 39.59 40.12 40.66 37.97 38.51 37.98 37.44

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 32.83 36.67 41.93 27.57 23.73 18.47 14.63
Fibonacci 31.04 33.19 36.67 27.57 24.09 21.94 18.47
Camarilla 29.83 30.67 31.50 27.57 28.17 27.33 26.50

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      63.38
    • P/E
      -
    • Book Value (Rs)
      62.22
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      30.90
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      0.60
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      62.58
      5-Day
      63.26
      8-Day
      57.80
      75.80

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      63.38
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      30.90
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      -
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      62.58
      5-Day
      63.26
      8-Day
      57.80
      75.80

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD

Action in Brooks Laboratories Ltd.

  • Technicals

    Brooks Labs closes above 150-Day Moving Average of 35.50 today.

    Jan 14

  • Technicals

    Brooks Labs closes above 50-Day Moving Average of 30.24 today.

    Jan 02

  • Technicals

    Brooks Labs closes above 30-Day Moving Average of 28.66 today.

    Dec 31

  • Technicals

    Brooks Labs closes above 30-Day Moving Average of 29.09 today.

    Dec 23

  • Technicals

    Brooks Labs closes above 30-Day Moving Average of 29.31 today.

    Dec 19

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 24.10 on NSE

    Dec 11, 09:22

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 25.60 on NSE

    Dec 10, 09:22

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 25.60 on NSE

    Dec 09, 15:24

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 25.00 on BSE

    Dec 06, 09:18

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 27.80 on NSE

    Dec 05, 11:36

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 28.80 on NSE

    Dec 04, 09:58

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 29.00 on NSE

    Dec 03, 15:08

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 25.05 on BSE

    Dec 02, 09:22

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 25.05 on BSE

    Dec 02, 09:16

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 25.05 on BSE

    Nov 26, 09:18

  • Technicals

    Brooks Labs closes below 30-Day Moving Average of 33.47 today.

    Nov 07

  • Technicals

    Brooks Labs closes below 50-Day Moving Average of 34.31 today.

    Nov 05

  • Technicals

    Brooks Labs closes above 50-Day Moving Average of 34.34 today.

    Nov 04

  • Technicals

    Brooks Labs closes below 30-Day Moving Average of 34.07 today.

    Oct 31

  • 52 Week Low

    Brooks Labs has hit 52wk low of Rs 30.40 on NSE

    Oct 15, 09:18

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 14.15 16.82 15.16 15.10 14.10
Other Income 0.07 0.07 2.46 0.10 0.05
PBDIT -1.92 -0.13 -2.43 -0.89 -1.50
Net Profit -1.88 -3.73 -6.94 -2.15 -2.00

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 16.19 16.19
Networth 105.15 114.48
Total Debt 28.33 25.80
Net Block 118.17 124.64
Investments 0.02 0.02
Total Assets 133.49 140.27

Historical Prices

On
Current Price %Gain / Loss
Open Price 55.25 38.05
-31.13
High Price 55.25 39.90
-27.78
Low Price 54.10 35.10
-35.12
Close Price 54.45 37.90
-30.39
Volume 2,320 2,457
5.91
On
Current Price %Gain / Loss
Open Price 56.00 38.10
-31.96
High Price 56.00 39.75
-29.02
Low Price 54.50 37.60
-31.01
Close Price 54.65 38.00
-30.47
Volume 10,224 38,491
276.48
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 12106.90 -63.00 -0.52
SENSEX 41115.38 -208.43 -0.50
NIFTY BANK 30701.45 -246.05 -0.80
NIFTY IT 16334.55 159.35 0.99
S&P BSE Smallcap 14633.16 -18.60 -0.13
Index Price Change %Chg
Nikkei 225 (Jan 23) 23,859.46 -171.89 -0.72
KOSPI (Jan 23) 2,249.72 -17.53 -0.77
Nasdaq (Jan 23) 9,383.77 12.96 0.14
DAX (Jan 22) 13,515.75 -40.12 -0.30
SGX Nifty (Jan 23) 12,149.00 9.00 0.07

CORPORATE ACTION

Date Agenda
Nov 13, 2019 Quarterly Results
Aug 14, 2019 Quarterly Results
Jun 11, 2019 Right Issue of Equity Shares
May 29, 2019 Audited Results
Feb 14, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
No Dividends Information is available for Brooks Laboratories
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Brooks Laboratories
Old FV New FV Ex-Split
No Splits Information is available for Brooks Laboratories
Ratio Premium Ex-Bonus
No Rights Information is available for Brooks Laboratories
Date Agenda
Sep 25, 2019 -
Jul 20, 2019 -
Aug 10, 2018 -
Sep 28, 2017 -
Sep 27, 2016 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2019 June 2019 March 2019 December 2018
Promoters 62.58 60.62 60.62 60.62
Pledged 0 0 0 0
FII/FPI 0 0 0 0
Total DII 7.38 8.8 9.21 10.73
Fin.Insts 0 0.01 0.01 0.13
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 7.38 8.79 9.2 10.6
Others 30.04 30.58 30.18 28.65
Total 100 100 100.01 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Brooks Labs 39.50 4.22 63.40 22.05 67.29 55.03 -14.81
Sun Pharma 446.25 -0.25 484.10 350.40 107070.32 10,303.21 816.60
Dr Reddys Labs 3060.05 0.09 3105.00 2065.30 50846.75 10,625.50 1,277.30
Divis Labs 1854.35 -0.84 1925.25 1460.55 49227.17 4,879.66 1,332.65
Cipla 471.75 -0.32 585.50 389.55 38033.79 12,374.01 1,888.41

COMPANY OVERVIEW

Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets. As of March 31, 2010, its product portfolio consist of 26 dry powder injections, 31 liquid injections, five tablets and two dry syrups. It manufactures a range of products on third party basis for companies, such as Zydus Cadila, Alembic, Intas, Wockhardt, Medley, Biochem, JB Chemical, PDPL and Sanat. Brooks Laboratories has a range of products catering to critical care segment in parental section, such as Beta Lactum, Cephalosporin, Carbapenems, General Dry powder Injectables and Liquid Injectables. Its Carbapenems products include Inj Ertapenem and Inj Meropenem. Its Liquid Injectables include Inj Nandrolone Decanoate, Inj Aceclofenac and Inj Midazolam.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Atul Ranchal

      Chairman

    • Rajesh Mahajan

      Managing Director

    • Rajnish Kumar Bedi

      Independent Director

    • Deepak Mahajan

      Independent Director

    • Sonia Gupta

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Brooks Laboratories Ltd.

Brooks Labs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS.

Related Searches